Psychoactive substances are natural or synthetic substances that act on the central nervous system and alter mental processes such as mood, perception, cognition, consciousness, and behaviour. These substances may be legally prescribed medications (e.g., pain medications or sedatives), legally available substances such as alcohol or caffeine, or controlled or illicit drugs. Psychoactive substances can be used for medical, social, cultural, or recreational purposes, but some carry risks of misuse, dependence, and health or social harms when used in harmful ways.
Psychoactive Substances
Handbook of Novel Psychoactive Substances: What Clinicians Should Know about NPS
Handbook of Novel Psychoactive Substances (NPS) provides a comprehensive overview of the challenges that clinicians face when dealing with NPS and discusses how the profile of patients and their socio-demographic characteristics frame the...
Novel Psychoactive Substances: Policy, Economics and Drug Regulation
In light of the recent emergence of Novel Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it...
Emerging Trends in Drugs, Addictions, and Health
Emerging Trends in Drugs, Addictions, and Health is a new international journal devoted to the rapid publication of authoritative papers on Novel Psychoactive Substances (NPS), Addiction and associated health phenomena. The Journal has a...
New psychoactive substances: A review and updates
New psychoactive substances (NPS) are a diverse group of substances that are linked with a number of health and social harms on an individual and societal level. NPS toxicity and dependence syndromes are recognised in primary care...
UNODC Early Warning Advisory on New Psychoactive Substances
The rapid emergence of a large number of New Psychoactive Substances on the global drug market poses a significant risk to public health and a challenge to drug policy. Often, little is known about the adverse health effects and social...
New psychoactive substances (NPS)
Overview A new psychoactive substance (NPS) is defined as 'a new narcotic or psychotropic drug, in pure form or in preparation, that is not controlled by the United Nations drug conventions, but which may pose a public health threat...
A Case study of the treatment of methamphetamine use disorder amongst medical students in Abia State, Nigeria - Chiamaka R. Nwaoru, Day 5, 09:00-10:30
Presented as part of the Uniting the global community to face the challenge of addiction event, online on 16th May, 2022
Psychiatric Co-Morbidity and Substance Use Associated with Medication Adherence Among People Living with HIV, Virology Clinic of University of Port Harcourt Teaching Hospital - Dr Aborlo Kennedy Nkporbu, Day 5, 09:00-10:30
Presented as part of the Uniting the global community to face the challenge of addiction event, online on 16th May, 2022.
Evidence for the universal, selective and indicated prevention of illicit substance use based on a systematic review and data science - Orlando Scoppetta, Day 4, 09:00-10:29
Presented as part of the Uniting the global community to face the challenge of addiction event, online on 15th May, 2022
Treatment, Day 3, Track 3, 13:30-15:00
Presented as part of the Uniting the global community to face the challenge of addiction event, in-person on 14th May, 2022